Cargando…

Protein Homeostasis in Amyotrophic Lateral Sclerosis: Therapeutic Opportunities?

Protein homeostasis (proteostasis), the correct balance between production and degradation of proteins, is essential for the health and survival of cells. Proteostasis requires an intricate network of protein quality control pathways (the proteostasis network) that work to prevent protein aggregatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Webster, Christopher P., Smith, Emma F., Shaw, Pamela J., De Vos, Kurt J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411428/ https://www.ncbi.nlm.nih.gov/pubmed/28512398 http://dx.doi.org/10.3389/fnmol.2017.00123

Ejemplares similares

Energy Homeostasis and Abnormal RNA Metabolism in Amyotrophic Lateral Sclerosis
por: Liu, Yu-Ju, et al.
Publicado: (2017)

Therapeutic Approaches Targeting Protein Aggregation in Amyotrophic Lateral Sclerosis
por: Malik, Ravinder, et al.
Publicado: (2020)

Investigating cell death mechanisms in amyotrophic lateral sclerosis using transcriptomics
por: Heath, Paul R., et al.
Publicado: (2013)

The Peripheral Nervous System in Amyotrophic Lateral Sclerosis: Opportunities for Translational Research
por: Gentile, Francesco, et al.
Publicado: (2019)

Amyotrophic lateral sclerosis-associated mutant VAPBP56S perturbs calcium homeostasis to disrupt axonal transport of mitochondria
por: Mórotz, Gábor M., et al.
Publicado: (2012)

Janus kinase inhibitors are potential therapeutics for amyotrophic lateral sclerosis
por: Richardson, Peter J., et al.
Publicado: (2023)

Proteinopathies as Hallmarks of Impaired Gene Expression, Proteostasis and Mitochondrial Function in Amyotrophic Lateral Sclerosis
por: Benson, Bridget C., et al.
Publicado: (2021)

Neuroimmunity dynamics and the development of therapeutic strategies for amyotrophic lateral sclerosis
por: Bowerman, Melissa, et al.
Publicado: (2013)

Protein Quality Control and the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Continuum
por: Shahheydari, Hamideh, et al.
Publicado: (2017)

Dysregulation of RNA-Binding Proteins in Amyotrophic Lateral Sclerosis
por: Xue, Yuan Chao, et al.
Publicado: (2020)

Prion-Like Propagation of Protein Misfolding and Aggregation in Amyotrophic Lateral Sclerosis
por: McAlary, Luke, et al.
Publicado: (2019)

Potential Preventive Strategies for Amyotrophic Lateral Sclerosis
por: Kuraszkiewicz, B., et al.
Publicado: (2020)

Amyotrophic Lateral Sclerosis: Proteins, Proteostasis, Prions, and Promises
por: McAlary, Luke, et al.
Publicado: (2020)

Kynurenine Pathway Metabolites as Biomarkers for Amyotrophic Lateral Sclerosis
por: Tan, Vanessa X., et al.
Publicado: (2019)

Motoneuron firing in amyotrophic lateral sclerosis (ALS)
por: de Carvalho, Mamede, et al.
Publicado: (2014)

Miro1 deficiency in amyotrophic lateral sclerosis
por: Zhang, Fan, et al.
Publicado: (2015)

Mitochondrial dynamism and the pathogenesis of Amyotrophic Lateral Sclerosis
por: Cozzolino, Mauro, et al.
Publicado: (2015)

Laryngeal Sensitivity in Patients with Amyotrophic Lateral Sclerosis
por: Ruoppolo, Giovanni, et al.
Publicado: (2016)

Role of Extracellular Vesicles in Amyotrophic Lateral Sclerosis
por: Ferrara, Deborah, et al.
Publicado: (2018)

Stress Granule Dysregulation in Amyotrophic Lateral Sclerosis
por: Dudman, Jessica, et al.
Publicado: (2020)

Basal ganglia alterations in amyotrophic lateral sclerosis
por: Castelnovo, Veronica, et al.
Publicado: (2023)

The Overlapping Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
por: Abramzon, Yevgeniya A., et al.
Publicado: (2020)

Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation
por: Mead, Richard J., et al.
Publicado: (2022)

Corrigendum: Prion-Like Propagation of Protein Misfolding and Aggregation in Amyotrophic Lateral Sclerosis
por: McAlary, Luke, et al.
Publicado: (2020)

Oxidative Stress as a Therapeutic Target in Amyotrophic Lateral Sclerosis: Opportunities and Limitations
por: Park, Hee Ra, et al.
Publicado: (2021)

Antibody-Based Therapeutic Interventions for Amyotrophic Lateral Sclerosis: A Systematic Literature Review
por: Poulin-Brière, Amélie, et al.
Publicado: (2021)

Targeted Genetic Screen in Amyotrophic Lateral Sclerosis Reveals Novel Genetic Variants with Synergistic Effect on Clinical Phenotype
por: Cooper-Knock, Johnathan, et al.
Publicado: (2017)

The Potential for Transition Metal-Mediated Neurodegeneration in Amyotrophic Lateral Sclerosis
por: Lovejoy, David B., et al.
Publicado: (2014)

Amyotrophic lateral sclerosis: a dying motor unit?
por: Piotrkiewicz, Maria, et al.
Publicado: (2013)

Are There Modifiable Environmental Factors Related to Amyotrophic Lateral Sclerosis?
por: Kuraszkiewicz, Bozenna, et al.
Publicado: (2018)

Abnormal Functional Connectivity Density in Amyotrophic Lateral Sclerosis
por: Li, Weina, et al.
Publicado: (2018)

Unraveling the Complexity of Amyotrophic Lateral Sclerosis Survival Prediction
por: Pfohl, Stephen R., et al.
Publicado: (2018)

Enteroviral Infection: The Forgotten Link to Amyotrophic Lateral Sclerosis?
por: Xue, Yuan Chao, et al.
Publicado: (2018)

Taxonomy Meets Neurology, the Case of Amyotrophic Lateral Sclerosis
por: Morello, Giovanna, et al.
Publicado: (2018)

Multifaceted Genes in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia
por: Ranganathan, Ramya, et al.
Publicado: (2020)

Pathological Proteins Are Transported by Extracellular Vesicles of Sporadic Amyotrophic Lateral Sclerosis Patients
por: Sproviero, Daisy, et al.
Publicado: (2018)

Opportunities for histone deacetylase inhibition in amyotrophic lateral sclerosis
por: Klingl, Yvonne E., et al.
Publicado: (2020)

Copper Homeostasis as a Therapeutic Target in Amyotrophic Lateral Sclerosis with SOD1 Mutations
por: Tokuda, Eiichi, et al.
Publicado: (2016)

Comparing therapeutic modulators of the SOD1 G93A Amyotrophic Lateral Sclerosis mouse pathophysiology
por: Lee, Albert J. B., et al.
Publicado: (2023)

The ER mitochondria calcium cycle and ER stress response as therapeutic targets in amyotrophic lateral sclerosis
por: Tadic, Vedrana, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ojhpo3ic6c61mb8l4upv1sbuvf